Correction: SMPDL3B a novel biomarker and therapeutic target in myalgic encephalomyelitis

Correction: SMPDL3B a novel biomarker and therapeutic target in myalgic encephalomyelitis

Saved in:

Bibliographic Details
Main Authors:	Bita Rostami-Afshari, Wesam Elremaly, Anita Franco, Mohamed Elbakry, Marie-Yvonne Akoume, Ines Boufaied, Atefeh Moezzi, Corinne Leveau, Pierre Rompré, Christian Godbout, Olav Mella, Øystein Fluge, Alain Moreau
Format:	Article
Language:	English
Published:	BMC 2025-08-01
Series:	Journal of Translational Medicine
Online Access:	https://doi.org/10.1186/s12967-025-06900-w
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

SMPDL3B a novel biomarker and therapeutic target in myalgic encephalomyelitis
by: Bita Rostami-Afshari, et al.
Published: (2025-07-01)

Plasma cell targeting with the anti-CD38 antibody daratumumab in myalgic encephalomyelitis/chronic fatigue syndrome—a clinical pilot study
by: Øystein Fluge, et al.
Published: (2025-07-01)

Myalgic Encephalomyelitis: A legal guide to the perplexed
by: W.P. de Villiers
Published: (2005-08-01)

Replicated blood-based biomarkers for myalgic encephalomyelitis not explicable by inactivity
by: Sjoerd Viktor Beentjes, et al.
Published: (2025-06-01)

Cytokines in the Cerebrospinal Fluids of Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis
by: D. Peterson, et al.
Published: (2015-01-01)

Neurodevelopment Genes Encoding Olduvai Domains Link Myalgic Encephalomyelitis to Neuropsychiatric Disorders
by: Mauricio Arcos-Burgos, et al.
Published: (2025-06-01)

Unwilling or unable? Interpreting effort task performance in myalgic encephalomyelitis/chronic fatigue syndrome
by: Andrew Kirvin-Quamme, et al.
Published: (2025-06-01)

Deep sequencing of BCR heavy chain repertoires in myalgic encephalomyelitis/chronic fatigue syndrome
by: Audrey A. Ryback, et al.
Published: (2025-02-01)

Circadian rhythm abnormalities and autonomic dysfunction in patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.
by: Trinitat Cambras, et al.
Published: (2018-01-01)

Medication use and symptomology in North American women with myalgic encephalomyelitis/chronic fatigue syndrome
by: Angela Pochakom, et al.
Published: (2025-06-01)

Comparative Study Between Cognitive Phenotypes of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Multiple Sclerosis
by: Mehdi Aoun Sebaiti, et al.
Published: (2025-02-01)

Predisposing and Precipitating Factors in Epstein–Barr Virus-Caused Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
by: Leonard A. Jason, et al.
Published: (2025-03-01)

Serial Paediatrics Omics Tracking in Myalgic Encephalomyelitis (SPOT-ME): protocol paper for a multidisciplinary, observational study of clinical and biological markers of paediatric myalgic encephalomyelitis/chronic fatigue syndrome in Australian adolescents aged 12–19 years
by: Adam Scheinberg, et al.
Published: (2024-12-01)

Letter: Time to correct the record on the global burden of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)
by: Maya Vardaman, et al.
Published: (2025-03-01)

RESTORE ME: a RCT of oxaloacetate for improving fatigue in patients with myalgic encephalomyelitis/chronic fatigue syndrome
by: Alan Cash, et al.
Published: (2024-11-01)

Patient experiences of remote consulting with chronic fatigue syndrome/myalgic encephalomyelitis and fibromyalgia: a qualitative study
by: Helen Leach, et al.
Published: (2025-04-01)

An integrative review on the orexin system and hypothalamic dysfunction in myalgic encephalomyelitis/chronic fatigue syndrome: implications for precision medicine
by: Noé López-Amador
Published: (2025-08-01)

Unravelling the Connection Between Energy Metabolism and Immune Senescence/Exhaustion in Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
by: Jente Van Campenhout, et al.
Published: (2025-03-01)

Stroop task and practice effects demonstrate cognitive dysfunction in long COVID and myalgic encephalomyelitis / chronic fatigue syndrome
by: James N Baraniuk, et al.
Published: (2024-11-01)

Oral minocycline therapy as first-line treatment in patients with Myalgic encephalomyelitis and long COVID: A pilot study
by: Kunihisa Miwa
Published: (2025-03-01)

Evaluating the Causal Role of Genetically Inferred Immune Cells and Inflammatory Cytokines on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
by: Lincheng Duan, et al.
Published: (2025-05-01)

Cerebrospinal fluid metabolomics, lipidomics and serine pathway dysfunction in myalgic encephalomyelitis/chronic fatigue syndroome (ME/CFS)
by: James N. Baraniuk
Published: (2025-03-01)

Under‐Served Groups and Myalgic Encephalomyelitis Research Workshop; Multiple Barriers to Effective Healthcare, Research and Public Participation
by: Monica Jane Bolton, et al.
Published: (2025-04-01)

Exploring barriers and facilitators to effective self-management in individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: an Interpretative Phenomenological Analysis
by: Molly Roberts, et al.
Published: (2025-12-01)

Two neurocognitive domains identified for patients with myalgic encephalomyelitis/chronic fatigue syndrome and post-acute sequelae of COVID-19
by: Ariadna Sandoval, et al.
Published: (2025-07-01)

Fatigue, interoplastic and nociplastic distress in myalgic encephalomyelitis/chronic fatigue syndrome, Gulf War Illness, and chronic idiopathic fatigue
by: Emily Chen, et al.
Published: (2025-08-01)

A Preliminary Comparative Assessment of the Role of CD8+ T Cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and Multiple Sclerosis
by: Ekua W. Brenu, et al.
Published: (2016-01-01)

Health-related quality of life in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Post COVID-19 Condition: a systematic review
by: Breanna Weigel, et al.
Published: (2025-03-01)

Beneficial effects of intermittent intravenous saline infusion in dysautonomic patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: a case-series
by: Per Sjögren, et al.
Published: (2025-07-01)

The potential therapeutic approaches targeting gut health in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): a narrative review
by: Chou-Yi Hsu, et al.
Published: (2025-05-01)

Key Pathophysiological Role of Skeletal Muscle Disturbance in Post COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Accumulated Evidence
by: Carmen Scheibenbogen, et al.
Published: (2025-02-01)

What can wage development before and after a G93.3 diagnosis tell us about prognoses for myalgic encephalomyelitis?
by: Anne Kielland, et al.
Published: (2025-01-01)

Relationship between major depressive disorder and myalgic encephalomyelitis/chronic fatigue syndrome: a two-sample mendelian randomization study analysis
by: Wenjing Song, et al.
Published: (2025-01-01)

Chronic fatigue syndrome (CFS) or myalgic encephalomyelitis (ME) is different in children compared to in adults: a study of UK and Dutch clinical cohorts
by: Esther Crawley, et al.
Published: (2015-10-01)

Association of Active Human Herpesvirus-6, -7 and Parvovirus B19 Infection with Clinical Outcomes in Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
by: Svetlana Chapenko, et al.
Published: (2012-01-01)

Defining a High-Quality Myalgic Encephalomyelitis/Chronic Fatigue Syndrome cohort in UK Biobank [version 1; peer review: 2 approved]
by: Gemma L. Samms, et al.
Published: (2025-04-01)

Elevated risk of new-onset chronic fatigue syndrome/myalgic encephalomyelitis up to four years after SARS-CoV-2 infection
by: Roham Hadidchi, et al.
Published: (2025-07-01)

Correction: Plasma cell targeting with the anti-CD38 antibody daratumumab in myalgic encephalomyelitis/chronic fatigue syndrome—A clinical pilot study
by: Frontiers Production Office
Published: (2025-08-01)

Correction: Chronic fatigue syndrome (CFS) or myalgic encephalomyelitis (ME) is different in children compared to in adults: a study of UK and Dutch clinical cohorts
Published: (2019-11-01)

Recovery from Myalgic Encephalomyelitis/Chronic Fatigue syndrome developed after severe acute respiratory syndrome coronavirus 2 vaccination: A case report
by: Isaku Kurotori, et al.
Published: (2025-06-01)